Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Journal of Clinical Neurology ; : 106-106, 2015.
Artículo en Inglés | WPRIM | ID: wpr-179188

RESUMEN

At the request of all of the authors, the corresponding author of this paper was changed to Dr. Jin Jun Luo.

2.
Journal of Clinical Neurology ; : 281-288, 2014.
Artículo en Inglés | WPRIM | ID: wpr-202211

RESUMEN

Homocysteine (Hcy) is a sulfur-containing amino acid that is generated during methionine metabolism. It has a physiologic role in DNA metabolism via methylation, a process governed by the presentation of folate, and vitamins B6 and B12. Physiologic Hcy levels are determined primarily by dietary intake and vitamin status. Elevated plasma levels of Hcy (eHcy) can be caused by deficiency of either vitamin B12 or folate, or a combination thereof. Certain genetic factors also cause eHcy, such as C667T substitution of the gene encoding methylenetetrahydrofolate reductase. eHcy has been observed in several medical conditions, such as cardiovascular disorders, atherosclerosis, myocardial infarction, stroke, minimal cognitive impairment, dementia, Parkinson's disease, multiple sclerosis, epilepsy, and eclampsia. There is evidence from laboratory and clinical studies that Hcy, and especially eHcy, exerts direct toxic effects on both the vascular and nervous systems. This article provides a review of the current literature on the possible roles of eHcy relevant to various neurologic disorders.


Asunto(s)
Femenino , Embarazo , Aterosclerosis , Demencia , ADN , Eclampsia , Epilepsia , Ácido Fólico , Homocisteína , Hiperhomocisteinemia , Metabolismo , Metionina , Metilación , Metilenotetrahidrofolato Reductasa (NADPH2) , Esclerosis Múltiple , Infarto del Miocardio , Sistema Nervioso , Enfermedades del Sistema Nervioso , Enfermedad de Parkinson , Plasma , Accidente Cerebrovascular , Vitamina B 12 , Vitaminas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA